The role of conservation in interpreting non-coding variants
As variant interpretation continues to shift beyond just coding regions, we’re increasingly faced with the challenge of making sense of non-coding variants — especially in intronic and intergenic regions. One of the most useful signals in this space is evolutionary conservation. When a base or region has remained unchanged across species, there’s a strong implication of functional importance. That’s why I’ve been relying more heavily on tools like CompassBioInfo, which help visualize conservation in parallel with regulatory annotations and gene models. It’s especially helpful when trying to explain why a seemingly “harmless” variant far from an exon might still warrant attention. In clinical discussions, having visual evidence of conservation can really shift the perspective on prioritization. I’d be curious to hear how others are integrating conservation into their variant review pipelines. Is it something you consider upfront, or only as supporting evidence when everything else is inconclusive?
Totally agree with both of you. Conservation gives us a valuable lens to evaluate function outside of protein-coding regions, which we often forget in the rush of clinical diagnostics. I think what’s held many teams back is the lack of intuitive tools for working with that data — but that’s changing quickly. Visual platforms like CompassBioInfo help make that layer of insight actionable, even for people without a deep bioinformatics background. When I show my colleagues a variant that overlaps a highly conserved region in the genome, it instantly changes how seriously they take it, even if there’s no direct annotation yet. That kind of interpretive power shouldn’t be underestimated. As more attention turns toward regulatory and deep intronic variants, I think conservation will move from a “nice to have” to a “must have” in every review workflow.